The leading representative office of defined VC is situated in the Tokyo. The company was established in Asia in Japan.
The overall number of key employees were 1.
Among the most popular portfolio startups of the fund, we may highlight Frequency Therapeutics. We can highlight the next thriving fund investment areas, such as Genetics, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Axil Capital, startups are often financed by gumi, U.S. Department of Defense, Taiwania Capital. The meaningful sponsors for the fund in investment in the same round are Taiwania Capital, RTW Investments LLC, Polaris Founders Capital. In the next rounds fund is usually obtained by Japan Science and Technology Agency.
The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
| Fund Name | Location |
| Activist Artists Management | California, United States, West Hollywood |
| Alliance Capital | Arizona, Scottsdale, United States |
| Alpine Investors | California, San Francisco, United States |
| Amelia Investments | - |
| Bison Capital (China) | Beijing, Beijing, China |
| Chengdu Hi-tech Investment Group | - |
| Garnett & Helfrich Capital | California, San Mateo, United States |
| Hansa Capital | Florida, Ponte Vedra Beach, United States |
| Hastings Equity Partners | Massachusetts, Needham, United States |
| Incept LLC | California, Sunnyvale, United States |
| Jiadel Medical | - |
| OMERS Private Equity | Canada, Ontario, Toronto |
| Ouest Angels Capital | France, Nantes, Pays de la Loire |
| RWE | Essen, Germany, Nordrhein-Westfalen |
| Somerset Capital | Colorado, Denver, United States |
| STS Ventures | Cologne, Germany, Nordrhein-Westfalen |
| Tecton Capital Partners LLC | England, London, United Kingdom |
| Tufts University | Massachusetts, Medford, United States |
| Zigg Capital | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GEXVal | $4M | 04 Dec 2023 | Fujisawa, Kanagawa Prefecture, Japan | ||
Cranebio | $2M | 04 Oct 2023 | Tokyo, Kantō, Japan | ||
Cellusion | $25M | 07 Jun 2023 | Chiyoda, Japan | ||
Suono Bio | 29 Mar 2021 | Cambridge, Massachusetts, United States | |||
TechsoMed | $7M | 03 Mar 2021 | Israel, Tel Aviv District, Israel | ||
JOLLY GOOD | $10M | 20 Jan 2021 | Chiyoda, Japan | ||
LUCA Science | $9M | 01 Sep 2020 | Japan, Chiyoda | ||
JOLLY GOOD | $910K | 25 Jul 2019 | Chiyoda, Japan | ||
Frequency Therapeutics | $62M | 23 Jul 2019 | Woburn, Massachusetts, United States |
– Suono Bio, Inc. is a biotech company based in Foxborough, Massachusetts.
– The company raised $8.5m in Series A funding.
– The round was led by Axil Capital and Mizuho Securities Principal Investment with participation from Taiwania Capital and other investors.
– The new funding will be used to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
– Suono Bio, Inc. has raised an $8.5m Series A financing led by Axil Capital and Mizuho Securities Principal Investment, with participation by Taiwania Capital and other investors.
– Suono Bio will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
– The company leverages technology developed in the laboratory of Institute Professor Robert Langer at the Massachusetts Institute of Technology (MIT) to facilitate rapid, local administration of therapeutics to treat serious diseases.
– The company was founded by Professor Langer, Professor Giovanni Traverso, from the Department of Mechanical Engineering at MIT and a gastroenterologist and biomedical engineer at Brigham and Women’s Hospital, Harvard Medical School, and Dr. Carl Schoellhammer.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GEXVal | $4M | 04 Dec 2023 | Fujisawa, Kanagawa Prefecture, Japan | ||
Cranebio | $2M | 04 Oct 2023 | Tokyo, Kantō, Japan | ||
Cellusion | $25M | 07 Jun 2023 | Chiyoda, Japan | ||
Suono Bio | 29 Mar 2021 | Cambridge, Massachusetts, United States | |||
TechsoMed | $7M | 03 Mar 2021 | Israel, Tel Aviv District, Israel | ||
JOLLY GOOD | $10M | 20 Jan 2021 | Chiyoda, Japan | ||
LUCA Science | $9M | 01 Sep 2020 | Japan, Chiyoda | ||
JOLLY GOOD | $910K | 25 Jul 2019 | Chiyoda, Japan | ||
Frequency Therapeutics | $62M | 23 Jul 2019 | Woburn, Massachusetts, United States |
